Clinical Trials Directory

Trials / Conditions / OCD

OCD

49 registered clinical trials studyying OCD17 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingLocating Biomarkers in OCD Through Behavioral Tasks
NCT03313622
Baylor College of Medicine
RecruitingImplementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings
NCT06934525
Bradley HospitalN/A
RecruitingRetrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments
NCT06997549
Neuronetics
RecruitingLight Therapy for Obsessive-compulsive Disorder (OCD)
NCT06720090
Washington University School of MedicineEARLY_Phase 1
RecruitingComputer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
NCT06624137
Yale University
RecruitingOpen-Label Psilocybin Study in Transdiagnostic Population
NCT06442423
Yale UniversityPhase 1
Active Not RecruitingTesting a Transdiagnostic TMS Treatment Target
NCT06282146
Brigham and Women's HospitalEARLY_Phase 1
RecruitingNeuromodulation for a Novel OCD Biomarker and Treatment
NCT05994053
Boston University Charles River CampusN/A
RecruitingBehavioural Development, Long-term Outcomes and Opportunities to Optimize Youth Mental Health Trajectories
NCT06978452
Douglas Mental Health University Institute
RecruitingDiscovering Factors in the Clinical Study Journey of Patients With OCD
NCT05881356
Power Life Sciences Inc.
RecruitingPersonalized DBS for OCD Guided by Stereoencephalography Mapping
NCT06347978
Andrew Moses Lee, MD, PhDN/A
RecruitingMulti-session, Personalized Cognitive Bias Modification for Thought-Action-Fusion
NCT06731426
Han Joo LeeN/A
RecruitingObjective Characterizatoion of Repetitive Behaviors
NCT06050369
Institut National de la Santé Et de la Recherche Médicale, FranceN/A
UnknownpBFS Guided High-dose rTMS Therapy for Treatment-Resistant Obsessive-Compulsive Disorder
NCT05964062
Changping LaboratoryN/A
UnknownpBFS Guided rTMS Therapy for Treatment-resistant Obsessive-Compulsive Disorder
NCT05964049
Changping LaboratoryN/A
RecruitingCerebral and Cognitive Markers of Treatment Resistance in Obsessive Compulsive Disorder
NCT05843604
Centre Hospitalier Henri Laborit
CompletedDoes TMS Affect Neuroplasticity? The Role of Brain-derived Neurotrophic Factor and Neuronal Cell Adhesion Mole
NCT06231095
Wroclaw Medical UniversityPhase 4
Active Not RecruitingA Clinical Trial of Tolcapone in Obsessive Compulsive Disorder
NCT05624528
University of ChicagoPhase 2
UnknownEffect of Pyridoxine as Add-on Therapy in OCD Patients
NCT06244121
Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshN/A
UnknownPsychiatric Orders in Psychoanalytic Treatment of ASD
NCT05930912
Yang I. Pachankis, PhD
RecruitingNeurostimulation Versus Therapy for Problems With Emotions
NCT05712057
Duke UniversityN/A
RecruitingPaired tVNS With ERP in OCD
NCT05580614
University of FloridaN/A
RecruitingHow Hormones and Exposure and Response Prevention (EX/RP) Affect the Brain of People With OCD
NCT05359562
University of PennsylvaniaN/A
RecruitingAccelerated TMS for Depression and OCD
NCT04982757
Weill Medical College of Cornell UniversityN/A
WithdrawnRole of Basal Ganglia and Thalamus in Perceptual Consciousness and Metacognition
NCT04461730
University Hospital, Grenoble
CompletedTherapist Guided, Parent-led, Cognitive Behavioural Therapy (CBT) for Preadolescent Children With Obsessive Co
NCT05981690
University of ReadingN/A
WithdrawnIndividual Versus Group Exposure With Response Prevention (ERP) for the Treatment of Obsessive Compulsive Diso
NCT03926546
Baylor College of MedicineN/A
UnknownEffect of N-acetylcysteine as Add on Therapy With SSRI in Moderate to Severe OCD Patients
NCT04904952
Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshN/A
WithdrawnDELPhI Evaluation of Psychiatric Conditions
NCT03842345
QuantalX Neuroscience
UnknownSertraline Combined With Fluvoxamine in the Treatment of Refractory Obsessive-compulsive Disorder
NCT04963257
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 4
CompletedArbitration Between Habitual and Goal-directed Behavior in Obsessive-compulsive Disorder: Circuit Dynamics and
NCT04075890
University of California, Los AngelesN/A
UnknownNeurofeedback for Treatment-resistant Obsessive-compulsive Disorder (OCD)
NCT03956771
Pedro MorgadoN/A
CompletedRapid Non-Invasive Brain Stimulation for OCD (oTMS)
NCT03404609
Stanford UniversityN/A
UnknownPersonalized Inhibitory Control Training for Compulsive Behavior Change
NCT03682913
Hebrew University of JerusalemN/A
UnknownImproving Access to Child Anxiety Treatment
NCT03528109
Bradley HospitalN/A
Active Not RecruitingMeasuring Automated Behavioral Observations & Vocal Expressions (ABOVE)
NCT03459456
Baylor College of Medicine
UnknownEffect of Vitamin C Upon SSRI-treated OCD Patients
NCT03754647
Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshN/A
Active Not RecruitingOpen/Aftercare Treatment for Participants Diagnosed With Obsessive Compulsive Disorder
NCT03511534
Stanford UniversityN/A
UnknownEvaluation of Capsulotomy by Linear Accelerator Radiosurgery in Severe and Refractory Obsessive-compulsive Dis
NCT02500888
Hospital de Clinicas de Porto AlegreN/A
CompletedDevelopment of an Instrument That Monitors Behaviors Associated With OCD
NCT02866422
University of Minnesota
CompletedEffects of Sertraline on Brain Connectivity in Adolescents With OCD
NCT02797808
University of MinnesotaPhase 1 / Phase 2
UnknownDifferences in Cognitive Performance and Brain Activity Between Patients With PTSD and OCD
NCT01723033
Beersheva Mental Health Center
CompletedModeling Between Plasma Concentration and Serotonin Transporter Occupancy Induced by Escitalopram in Obsessive
NCT01936051
Seoul National University Hospital
CompletedRandomized Controlled Meditation Trial for Treating OCD
NCT01833442
University of Sao PauloN/A
UnknownThe Imaging Genetic Study of the Core Family of Obsessive-compulsive Disorder (OCD) Patient
NCT01298622
Kunming Medical University
UnknownTolerability And Efficacy Of High Dose Escitalopram In The Treatment Of Patients Suffering From Schizophrenia
NCT00708396
BeerYaakov Mental Health CenterPhase 4
CompletedRiluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder
NCT00523718
Yale UniversityPhase 2
CompletedPilot Study to Evaluate Escitalopram in Obsessive-compulsive Disorder
NCT00215137
Duke UniversityPhase 2
WithdrawnTreatment With Duloxetine for OCD Patients
NCT00399022
Sheba Medical CenterN/A